Perspectives on the management of coronary artery disease in India

Heart

Volumn 93, Issue 11, 2007, Pages 1334-1338

  Karthikeyan, Ganesan ^b   Xavier, Denis ^a   Prabhakaran, Doriaraj ^b   Pais, Prem ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; METOPROLOL; MEVINOLIN;

ACUTE CHEST SYNDROME; ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ANGIOPLASTY; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; CORONARY ARTERY DISEASE; GENETIC HETEROGENEITY; HEART REHABILITATION; HOSPITAL CARE; HUMAN; INDIA; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SMOKING; ST SEGMENT ELEVATION; STROKE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; METHODOLOGY; STANDARD;

ACUTE CORONARY SYNDROME; CORONARY ARTERY DISEASE; DELIVERY OF HEALTH CARE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INDIA; QUALITY OF HEALTH CARE;

EID: 38449120973     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.131193     Document Type: Review

References (46)

1. Reddy KS. Cardiovascular diseases in non-Western countries. N Engl J Med 2004;350:2438-40.
2. Gajalakshmi V, Peto R. Verbal autopsy of 80,000 adult deaths in Tamilnadu, south India. BMC Public Health 2004;4:47.
3. Joshi R, Cardona M, Iyengar S, et al. Chronic diseases now a leading cause of death in rural India - mortality data from the Andhra Pradesh Rural Health Initiative. Int J Epidemiol 2006;35:1522-9.
4. Bahl VK, Prabhakaran D, Karthikeyan G. Coronary artery disease in Indians. Indian Heart J 2001;53:707-13.
5. Ahmad N, Bhopal R. Is coronary heart disease rising in India? A systematic review based on ECG defined coronary heart disease. Heart 2005;91:719-25.
6. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.
7. Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020, Cambridge, Mass. : Harvard University Press, 1996.
8. Indrayan A. Forecasting cardiovascular disease cases and associated mortality in India. New Delhi: National Commission for Macroeconomics and Health, Government of India, 2004.
9. Abegunde D, Stanciole A. An estimation of the economic impact of chronic noncommunicable diseases in selected countries, World Health Organization. Geneva 2006. Available at http://www.who.int/entity/chp/ working_paper_growth%20model29may.pdf (accessed 18 August 2007).
10. WHO. The World Health Report 2000 - Health systems: improving performance. Geneva: WHO, 2000.
11. Suhrcke M, Nugent RA, Stuckler D, et al. Chronic disease: an economic perspective. London: Oxford Health Alliance, 2006, Available at http://www.oxha.org/initiatives/economics/chronic-disease-an-economic- perspective (accessed 18 August, 2007).
12. Luepker RV, Raczynski JM, Osganian S, et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. JAMA 2000;284:60-7.
13. Anand SS, Pais P, Pogue J, et al. A comparison of practice patterns for acute myocardial infarction between hospitals in Canada and India. Indian Heart J 1997;49:35-41.
14. George E, Savitha D, Pais P. Pre-hospital issues in acute myocardial infarction. J Assoc Physicians India 2001;49:320-3.
15. Rajagopalan RE, Chandrasekaran S, Pai M, et al. Pre-hospital delay in acute myocardial infarction in an urban Indian hospital: a prospective study. Natl Med J India 2001;14:8-12.
16. Malhotra S, Gupta M, Chandra KK, et al. Prehospital delay in patients hospitalized with acute myocardial infarction in the emergency unit of a north Indian tertiary care hospital. Indian Heart J 2003;55:349-53.
17. George E, Hunsberger, Savitha D, et al. Treatment of acute myocardial infarction: Does the type of hospital make a difference? Indian Heart J 1999;51:161-6.
18. Yusuf S, Mehta SR, Xie C, et al. CREATE Trial Group Investigators. Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation. JAMA 2005;293:427-35.
19. Prabhakaran D, Yusuf S, Mehta S, et al. Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS Registry 1 and 2. Indian Heart J 2005;57:217-25.
20. Yusuf S, Hawken S, Ounpuu S, et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study. Lancet 2004;364:937-52.
21. Joshi P, Islam S, Pais P, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 2007;297:286-94.
22. Teo KK, Ounpuu S, Hawken S, et al. INTERHEART Study Investigators. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006;368:647- 58.
23. Pais P, Fay MP, Yusuf S. Increased risk of acute myocardial infarction associated with beedi and cigarette smoking in Indians: final report on tobacco risks from a case-control study. Indian Heart J 2001;53:731-5.
24. Bradley EH, Herrin J, Elbel B, et al. Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA 2006;296:72-8.
25. Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases: Part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104:2855-64.
26. Mohan V, Deepa R, Rani SS, et al. Chennai Urban Population Study (CUPS No 5). Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: the Chennai Urban Population Study (CUPS No 5). J Am Coll Cardiol 2001;38:682-7.
27. Deepa M, Farooq S, Datta M, et al. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev 2007;23:127-34.
28. Mendis S, Abegunde D, Yusuf S, et al. WHO study on Prevention and REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). Bull World Health Organ 2005;83:820-8.
29. Deepa R, Shanthirani CS, Pradeepa R, et al. Is the 'rule of halves' in hypertension still valid? - Evidence from the Chennai Urban Population Study. J Assoc Physicians India 2003;51:153-7.
30. Reddy KS, Prabhakaran D, Chaturvedi V, et al. Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations. Bull World Health Organ 2006;84:461-9.
31. Prabhakaran D, Shah P, Chaturvedi V, et al. Cardiovascular risk factor prevalence among men in a large industry of northern India. Natl Med J India 2005;18:59-65.
32. Malhotra S, Karan RS, Pandhi P, et al. Pattern of use and pharmacoeconomic impact of antihypertensive drugs in a north Indian referral hospital. Eur J Clin Pharmacol 2001;57:535-40.
33. Yusuf S. Two decades of progress in preventing vascular disease. Lancet 2002;360:2-3.
34. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419-24.
35. Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 2006;368:679-86.
36. Connor J, Rafter N, Rodgers A. Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. Bull World Health Organ 2004;82:935-9.
37. Xavier D, Devereaux PJ, Goyal A, et al. Polypharmacotherapy for primary prevention of cardiovascular disease. Indian Heart J (in press).
38. Kodungati SC. Coronary intervention data in India for the year 2005. Indian Heart J 2006;58:282-4.
39. Hochman JS, Lamas GA, Buller CE, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006;355:2395-407.
40. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-16.
41. World Health Organization. Macroeconomics and health: investing in health for economic development - report of the Commission on Macroeconomics and Health. Geneva: WHO, 2001.
42. Gaziano TA, Reddy KS, Paccaud F, et al. Cardiovascular disease. Disease control priorities in developing countries, 2nd ed. New York: Oxford University Press, 2006:645-662.
43. Gupta R, Prakash H, Gupta RR. Economic issues in coronary heart disease prevention in India. J Hum Hypertens 2005;19:655-7.
44. Lip GY, Luscombe C, McCarry M, et al. Ethnic differences in public health awareness, health perceptions and physical exercise: implications for heart disease prevention. Ethn Health 1996;1:47-53.
45. Farooqi A, Nagra D, Edgar T, et al. Attitudes to lifestyle risk factors for coronary heart disease amongst South Asians in Leicester: a focus group study. Fam Pract 2000;17:293-7.
46. Webster RA, Thompson DR, Mayou RA. The experiences and needs of Gujarati Hindu patients and partners in the first month after a myocardial infarction. Eur J Cardiovasc Nurs 2002;1:69-76.